Edayan, Cesar M.

HRN: 26-09-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2024
CEFTRIAXONE 1G (VIAL)
10/29/2024
11/04/2024
IV
2g
OD
Laceration Wound
Waiting Final Action 
10/29/2024
MUPIROCIN 2%, 15G (TUBE)
10/29/2024
11/04/2024
TOPICAL
Pea Size
Q8
Abrasion Wound
Waiting Final Action 
10/29/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/29/2024
11/04/2024
IV
600mg
Q6
Bone Fracture
Waiting Final Action 
10/31/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/31/2024
11/07/2024
IV
500mg
Q6
S/P ORIF Tibia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: